about
Genetics of coronary artery disease and myocardial infarctionSerum Levels of Glycoproteins are Elevated in Patients with Ovarian CancerIdentified single-nucleotide polymorphisms and haplotypes at 16q22.1 increase diabetic nephropathy risk in Han Chinese populationOral streptococci utilize a Siglec-like domain of serine-rich repeat adhesins to preferentially target platelet sialoglycans in human blood.Improvement in Depressive Symptoms Is Associated with Reduced Oxidative Damage and Inflammatory Response in Type 2 Diabetic Patients with Subsyndromal Depression: The Results of a Randomized Controlled Trial Comparing Psychoeducation, Physical ExercN-Acetylneuraminic acid attenuates hypercoagulation on high fat diet-induced hyperlipidemic rats.N-Acetylneuraminic Acid Supplementation Prevents High Fat Diet-Induced Insulin Resistance in Rats through Transcriptional and Nontranscriptional Mechanisms.Metabolic biomarkers for predicting cardiovascular disease.Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia.Mutation in ST6GALNAC5 identified in family with coronary artery disease.Synthesis and cardiovascular protective effects of quercetin 7-O-sialic acid.Total and lipid bound sialic acid levels in patients with polycystic ovary syndrome.The relationship between serum sialic acid and high-sensitivity C-reactive protein with prehypertension.High-throughput analysis of intraclonal variability of glycoprotein sialylation.The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.Cell and Tissue Imaging with Molecularly Imprinted Polymers.Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk.Association between protein-bound sialic acid and high-sensitivity C-reactive protein in essential hypertension: a possible indication of underlying cardiovascular risk.Benefits of Zubex beyond glycemic control: Evidence of the antiatherogenic effect.The association of serum sialic acid with carotid intima-media thickness and anthropometric and metabolic parameters in obese children and adolescents.Chitosan-modified silver@ruthenium hybrid nanoparticles: evaluation of physico-chemical properties and bio-affinity with sialic acid
P2860
Q26769994-937CCEA8-5DC7-4B86-89B0-3C81DBE68249Q33774597-A6EDFE41-E96C-438F-B097-EDBE26CF499FQ34463264-6BEB1ACB-1DA5-432E-9CF9-54454BACA70DQ34634780-7931E38C-8379-4845-9B9C-E55BA19E0EE7Q35988995-0E1A119D-4172-4A12-AA4C-3CE31EE2E964Q36351051-ED961AB5-8781-4658-8793-E8874F3C0982Q36356598-C7BAFEB9-B738-4BB4-91B4-9E11CCECD876Q36584772-7608CC72-D88B-4186-A791-19DE41359678Q37332205-001C9976-D534-41B2-8315-52DA46270C05Q37447185-325DC090-1CA3-4A6B-8A9F-F967CE62923DQ37539955-DC905E45-1A90-433A-8CFC-AB51AB1EBF3EQ37611155-07A37FD6-256E-4109-A9C6-959FAB112171Q37698392-CDB21253-E3DA-4FDC-8A71-60EE133768B7Q39446586-382D4C74-6F35-40F3-8A11-E675746B63C8Q39735549-53648369-0C88-46E7-BCA1-88D0C03321B1Q40310168-D445DA68-081B-419F-98B0-AE78C6FD4ABAQ46478912-EF7F0B6D-42CD-4025-A690-A2FD2941BEFCQ46664917-3C3A0085-6239-43C8-BA2E-4D2BC857EB88Q51285494-6AAF000F-8AD6-4570-AC98-45E7E185885DQ51364403-9A9B7579-6F0C-455D-9482-5B2C200E2D45Q58357105-42F23A1A-E268-4D27-B67A-807EBF46B2E5
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Sialic acid: a novel marker of cardiovascular disease?
@ast
Sialic acid: a novel marker of cardiovascular disease?
@en
type
label
Sialic acid: a novel marker of cardiovascular disease?
@ast
Sialic acid: a novel marker of cardiovascular disease?
@en
prefLabel
Sialic acid: a novel marker of cardiovascular disease?
@ast
Sialic acid: a novel marker of cardiovascular disease?
@en
P1476
Sialic acid: a novel marker of cardiovascular disease?
@en
P2093
Karina P Gopaul
Martin A Crook
P304
P356
10.1016/J.CLINBIOCHEM.2006.02.010
P577
2006-04-19T00:00:00Z